Page Title
Clinical Trial Finder
Observational Closed to Enrollment
Observational study comparing home to office spirometry in children 6 years of age and older and adults with cystic fibrosis. (OUTREACH-OB-22)
This is an observational study and includes no experimental drugs or events. This study is comparing home to office measuring of lung function, height, and weight. The aim of the study is to know more about the accuracy of these measurements when they are obtained at home as compared to their being obtained in the clinic.
Participants will have three in-person visits where lung function, height, and weight are measured. Within one week of each in-person visit, participants will measure lung function, height, and weight at home.This study may require measuring of lung function and completion of questionnaires.
Eligibility
-
Age:
6 Years and Older -
Mutation(s):
No Mutation Requirement -
FEV1% Predicted:
No FEV1 Limit
For more information about the results of this study and where it was conducted, visit ClinicalTrials.gov.
Study Design
-
Study Type: ?more info
Observational -
Randomized Study: ?more info
No -
Placebo Controlled: ?more info
No -
Length of Participation:
4 months -
Number of Study Visits:
4
Additional Information
-
Phase: ?more info
Not Applicable -
Study Sponsor: ?more info
Rosenfeld, Margaret -
Study Drugs:
N/A
Study Sites
-
Closed to Enrollment
Alaska
Providence Alaska Medical Center, Anchorage, AK 99508
-
Closed to Enrollment
Arkansas
Arkansas Children's Hospital, Little Rock, AR 72202
-
Closed to Enrollment
Illinois
OSF Saint Francis Medical Center, Peoria, IL 61637
-
Closed to Enrollment
Massachusetts
Boston Children's Hospital, Boston, MA 02115
-
Closed to Enrollment
Michigan
Wayne State University Harper University Hospital, Detroit, MI 48201
-
Closed to Enrollment
Michigan
Corewell Health Helen DeVos, Grand Rapids , MI 49503
-
Closed to Enrollment
Missouri
St. Louis Children's Hospital, St. Louis, MO 63110
-
Closed to Enrollment
New York
Lenox Hill Hospital Cystic Fibrosis Center, New York, NY 10028
-
Closed to Enrollment
North Carolina
Atrium Health Wake Forest Baptist, Winston-Salem, NC 27157
-
Closed to Enrollment
Ohio
Toledo Children's Hospital, Toledo, OH 43606
-
Closed to Enrollment
Ohio
Children's Hospital Medical Center of Akron, Akron, OH 44308
-
Closed to Enrollment
Oregon
Oregon Health & Science University, Portland, OR 97239
-
Closed to Enrollment
Pennsylvania
Jefferson University Hospital, Philadelphia, PA 19107
-
Closed to Enrollment
South Carolina
Prisma Health Children's Hospital - Midlands, Columbia, SC 29203
-
Closed to Enrollment
South Dakota
Sanford USD Medical Center, Sioux Falls, SD 57117
-
Closed to Enrollment
Texas
The Adult Cystic Fibrosis Center of Central Texas, Austin, TX 78705
-
Closed to Enrollment
Washington
Seattle Children's Hospital, Seattle, WA 98105
-
Closed to Enrollment
Washington
Providence Medical Group, Cystic Fibrosis Clinic, Spokane, WA 99204
-
Closed to Enrollment
Wisconsin
Froedtert & Medical College of Wisconsin, Milwaukee, WI 53226
Eligibility
-
Age:
6 Years and Older -
Mutation(s):
No Mutation Requirement -
FEV1% Predicted:
No FEV1 Limit
For more information about the results of this study and where it was conducted, visit ClinicalTrials.gov.
Sign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Check the Drug Development Pipeline
We’re attacking CF from every angle. Learn about the status of CF drugs in development.
Learn More